ITGB1BP1 (integrin subunit beta 1 binding protein 1) is a key negative regulator of integrin α5β1 activation that controls cell-matrix adhesion dynamics. The protein functions by binding to the ITGB1 cytoplasmic tail and competing with talin to prevent integrin clustering at focal adhesions, thereby modulating focal adhesion assembly and osteoblast spreading on fibronectin and collagen 1. ITGB1BP1 also acts as a guanine nucleotide dissociation inhibitor for Rho family GTPases (CDC42 and RAC1), reducing their active GTP-bound states during cell adhesion, and regulates ROCK-mediated contractility through monoubiquitylation by Smurf1, serving as a molecular switch coordinating extracellular matrix density and rigidity sensing 1. In angiogenesis, ITGB1BP1 functions as a negative regulator, attenuating endothelial cell proliferation and migration through Notch pathway activation. Clinically, ITGB1BP1 emerges as a significant prognostic marker in hepatocellular carcinoma, incorporated into an integrin-based signature predicting patient outcomes independently of standard clinicopathological parameters 2. The gene shows involvement in bone mineralization, myoblast migration on laminin, and appears in genome-wide adaptation studies of African cattle alongside implications for human diseases 3. Additionally, ITGB1BP1 may serve as a computational target in plant-derived miRNA cross-kingdom regulation studies with potential disease relevance 4.